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ABSTRACT
Introduction Epidemiological data on dementia is not 
available in many European countries and regions due to 
the high cost and complexity of conducting large scale 
dementia screening studies. The available epidemiological 
studies identify potentially substantial variation in the 
prevalence of dementia over time and across Europe.
Methods In this paper we generate simulations of 
the number of dementia cases in Ireland from 1991 to 
2036 using a three- state Markov illness- death model. 
Parameters values are selected for each simulation 
from a range using a random parameter search pattern. 
We employ a novel calibration method which exploits 
the strong relationship between dementia, ageing and 
mortality. Simulation weights are generated based on 
differences between observed and modelled cohorts of 
older people and the reported number of deaths from 
dementia. Irish Census data from 1991 to 2016 and the 
number of recorded deaths due to dementia in 2018 are 
used as calibration points. A weighted average projection 
of the number of dementia cases is generated.
Results We estimate a weighted average number of 
cases of dementia in 2016 of 54 877 increasing to 98 
946 in 2036; this estimate is substantially lower than 
the estimates generated using extrapolation methods. 
We show the wide range of possible outcomes given the 
range in the available parameter estimates and show that 
irrespective of whether the incidence rate of dementia 
is declining the number of cases of dementia is rapidly 
increasing due to population ageing.
Conclusion Previous studies have used parameter 
estimates from meta- analyses of the literature or from 
individual studies. In this paper we supplement these with 
a calibration approach using observed cause of death and 
population age structure data. These additional sources 
of data can be used to generate estimates of dementia 
prevalence in any country or region which has census data 
and data on deaths due to dementia.
INTRODUCTION
Dementia is a chronic or progressive 
syndrome characterised by deterioration in 
memory, thinking, behaviour and the ability 
to perform everyday activities.1 The number 
of people living with dementia continues to 
increase, currently the condition affects an 
estimated 50 million people worldwide with 
a global cost estimated to reach US$1 trillion 
in 2018.2 People with dementia, particularly 
moderate- to- severe dementia, have extensive 
health and social care needs.3
For policymakers to plan for current and 
future needs, guidance on the number of 
people with dementia and their care needs is 
required. However, many countries have little 
or no epidemiological data on dementia.4 
Due to the substantial cost of large scale 
screening studies, many countries are likely 
to remain without local, population repre-
sentative prevalence estimates in the foresee-
able future.5 Pragmatic solutions are required 
which would exploit available national data 
to generate robust estimates of dementia 
prevalence for service planning purposes, 
particularly given the increasing prevalence 
of dementia and the challenge posed to the 
sustainability of health systems by chronic 
conditions.6
Many of the European epidemiological 
studies of dementia were carried out in the 
1980s and 1990s.7 There are indications 
from a small number of more recent large 
scale studies that incidence (the number of 
Strengths and limitations of this study
 ► This study demonstrates a method for generating 
robust estimates of the number of cases of demen-
tia that can be applied to any country or region with 
census data and cause of death data.
 ► The study provides estimates and projections of the 
number of cases of dementia in Ireland that are con-
sistent with available Irish data.
 ► We show the growth and the credible range in the 
number of cases of dementia for the projection pe-
riod. These are key requirements for planning future 
healthcare needs.
 ► The quality of data on dementia as a cause of death 
in Ireland is currently poor; this study provides a mo-
tivation for gathering data on dementia as a cause 
of death.
 ► While we have used the best available epidemio-
logical data from the literature, the results may be 
sensitive to the modelling assumptions.
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new cases per year) and prevalence rates for dementia 
(the total number of cases) may have declined.8 Though 
comparison is difficult due to differences in study 
methods, there is some evidence that prevalence rates 
may vary between countries and regions of the world.9 
Variation in prevalence rates have also been shown within 
large countries,10 11 a recent study using German admin-
istrative data demonstrated the wide variation in the 
prevalence of dementia within Germany—with age stan-
dardised prevalence rates of between 6 and 10 per cent of 
people over 65 years of age.11
A range of risk factors for dementia have been identified 
including: hearing loss, education level, genetics (APOE 
e4 gene), smoking, depression, social isolation, phys-
ical activity, diabetes, obesity and hypertension; in addi-
tion to age.12 The prevalence of these risk factors varies 
widely across Europe. For example, the prevalence of the 
APOE e4 gene, is higher in the Scandinavian countries 
and lower in southern Europe.13 Other than age, mid- life 
hearing loss is potentially the most important risk factor 
for dementia.12 While wide variation in rates of hearing 
loss have been found across countries, methodological 
consistency in this area is low.14 However, how the risk 
factors of dementia are inter- related and the mechanisms 
through which they alter the incidence and prevalence 
of dementia are not well understood. Improvements in 
education and reductions in smoking and hypertension 
may be influencing the reduction in the incidence of 
dementia despite increases in obesity and physical inac-
tivity in many countries.15 16 What is clear is that there is a 
significant potential for cross- country and within- country 
regional differences in prevalence rates of dementia.
The prevalence of dementia in Ireland currently used 
for service planning has been calculated using a meta- 
analysis of international studies resulting in an estimate 
of 55 000 people with dementia.17 These estimates have 
been used to establish rates of provision for different 
services in Ireland and to examine regional differences 
to guide future resource allocation.18 However, if preva-
lence rates from a recent large scale study in the UK19 
were to be used, these estimates would be substantially 
lower.20 The national dementia strategy calls for improved 
national estimates of current and future prevalence of 
dementia.21 More sophisticated estimates would facilitate 
scenario planning for future capacity.22 Such scenarios 
could explore the potential for responding to public pref-
erences for home care23 24 and examine, for example, the 
optimal balance of home care and residential care while 
responding to increases in the number of people with 
dementia.
In this paper we generate a set of simulations based on 
international epidemiological data from 1991 to 2036. 
By generating simulations based on parameter ranges 
rather than point estimates we demonstrate the poten-
tial range of the number of cases of dementia in Ireland 
based on the available evidence, which facilitates more 
accurate planning, and scenario- based planning for 
future resource allocation. A novel contribution of this 
paper is to calibrate these simulations using Irish census 
data and the number of deaths due to dementia in 2018. 
This allows us to estimate a weighted average number 
dementia cases for the projection period that are consis-
tent with the available Irish data.
METHODS
Projections of the number of people with dementia have 
previously been carried out in Ireland and elsewhere by 
multiplying historical population dementia prevalence 
rates by future population projections for each age- 
gender group.25 This extrapolation method benefits from 
being simple, however it may lead to biassed projections 
if the age and gender specific prevalence rates vary over 
time.26 For example, if incidence rates are in decline this 
would not be captured in historical prevalence studies. 
In addition, it is not clear what prevalence rates should 
be used; in the Irish context this could, for instance, be 
data from an international meta- analysis27 or the most 
recent UK study.19 While many of the behavioural risk 
factors in Ireland are likely to be similar to those of the 
UK, we cannot be confident that the major risk factors 
are well aligned, leading to biassed projections. We know 
relatively little about hearing loss in different areas, there 
are educational differences between Ireland and the UK 
and the prevalence of the APOE e4 gene in Ireland is not 
available.
An alternative approach to generating projections is by 
macro- simulation. This involves modelling the aggregate 
flows of older people between age groups and dementia 
states.28 A key advantage of macro- simulation over the 
simpler extrapolation approach is that more nuanced 
alternative scenarios of changing incidence and mortality 
can be considered.
Macro- simulations, to generate the projected number 
of dementia cases, have been carried out for the USA29 
and a number of European countries.30 31 However, none 
of these papers have used census data to calibrate their 
projections. Generating a macro- simulation model of 
dementia prevalence rates requires assumptions about 
the initial prevalence of dementia in the population; inci-
dence rates over the study period; and mortality rates for 
both the dementia and non- dementia populations. For 
this exercise, these are sourced from the international 
literature (outlined below) as there have been no large 
scale epidemiological studies of dementia in Ireland.
Model overview
A multi- state Markov illness- death model is used to simu-
late the number of people in all age cohorts in each of 
three states—no dementia, dementia and dead.32 33 The 
flows between these states are determined by the number 
of people in a state and the transition probabilities 
between states. Transition probabilities for dementia inci-
dence and mortality (from dementia and non- dementia 
causes) vary by year, age and gender. The total number 
of people in age cohort i at time t, denoted by Cit, is 
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calculated as:  Cit = Nit + N
∗
it  , where N (N*) is the number 
of people in that cohort without (with) dementia. The 
number of people in the non- dementia age cohort i in 
period t is determined by the number of individuals in 
that cohort in the preceding period, adjusted by the prob-
ability of individuals having died in that period  (Mit−1) , 
and the incidence rate for dementia  (Iit−1) , defined as the 
number of new dementia cases in the age cohort over the 
number of individuals in the cohort in that year.
 Nit = Nit−1
(
1 − Mit−1 − Iit−1
)
 (1)
Non- dementia mortality is modelled as an exponential 
function with a separate time trend for the historical and 
the projection periods.
 Mit−1 = exp
(
MIntercept + MAge ∗ i + Mtr1∗t1 + Mtr2∗t2
)
 (2)
Where  MIntercept  and  MAge  are coefficients of the base 
mortality model.  Mtr1  is the trend for the 1991 to 2016 
period (t1) and  Mtr2  is the trend in the projection period 
(t2). The number of people in the dementia age cohort 
i in period t is determined by the number of individ-
uals in that cohort in the preceding period reduced by 
individuals having died in that period, and increased 
by the number of new dementia cases. The probability 
of mortality in the dementia state is the product of the 
non- dementia mortality rate  (Mit−1)  and the mortality rate 
of people with dementia relative to the mortality rate of 
people without dementia (RMi). RMi decays with age at 
a rate of RMDecay. RM65 and RMDecay are linked such that 
a high relative mortality rate at 65 years of age coincides 







1 − RMi ∗ Mit−1
)
+ Nit−1 ∗ Iit−1 (3)





The incidence of dementia has been shown to exhibit 
exponential growth with increasing age.34 Incidence is 
modelled as follows:
 Iit−1 = I65 ∗
(
1 + Itr
)t ∗ (1 + Igrowth
)i
 (5)
Where  I65  is the incidence of dementia at 65 years of 
age in 1991,  Itr  is the trend in  I65  over time and  Igrowth  is the 
increase in incidence rates with age. Together, equations 
1 to 5 allow the model to project the number of individ-
uals in the dementia and non- dementia states over time, 
given a number of inputs which are discussed below. Five 
thousand simulations are generated for both men and 
women. Simulations are generated for single year- age 
cohorts of men and women between 65 and 98 years of 
age. The minimum and maximum ages of 65 years and 98 
years are used as there is sparse available data on the inci-
dence/prevalence of dementia for younger people with 
dementia and in the oldest old.35 36
Simulations were carried out on R (V.3.6) using the 
heemod package.33
Model parameters
Parameters are selected for each simulation from a distri-
bution using a random parameter search pattern.37 This 
approach generates a set of parameters for each simula-
tion by selecting values at random from a range provided 
for each parameter. The choice of potential parameter 
values for these inputs was informed by a review of the 
literature outlined below. The parameter ranges used are 
summarised in online supplementary table 1. With the 
exception of the incidence rate, all parameter values are 
selected from a uniform distribution.
Incidence rate at 65 in 1991
International studies of incidence have produced a wide 
range of estimates.38 The incidence rate for men and 
women at aged 65 in 1991 is selected from a truncated 
normal distribution with a mean of 4.2 cases per 1000, 
based on an interpolation of the 60 to 64 and 65 to 69 
categories,2 a maximum of 8.2 cases per 100039 and a 
minimum of 2.3 cases per 1000.40 A floor for incidence 
rate at 65  (I65)  is set at 1.5 cases per 1000 to maintain a 
positive prevalence of dementia.
Increase in incidence with age (Igrowth) 
Incidence rates have been shown to double every 5.8 
years, which is equivalent to an increase of 12 per cent 
in the incidence rate for every year of age.2 The search 
range for this parameter is from 11 to 13 per cent per 
year.
Trend in incidence rates (Itr) 
There are indications from a number of large scale 
studies that incidence rates have declined over time. In 
the US Framingham Heart Study, a decline in dementia 
incidence rates of 3 per cent per year was found. In the 
UK, the Cognitive Functioning and Ageing Study showed 
a decline in incidence rates between the early 1990s and 
the late 2000s of 20 per cent, or 2 per cent per year.39 
A decline in incidence may be due to reduced exposure 
to dementia risk factors (eg, healthier lifestyles) and/or 
increased exposure to protective factors (such as educa-
tion) (ibid). The possible effect of preventative measures 
is operationalised in the paper through a decay in the 
incidence rate of between 0 and 2 per cent per calendar 
year.
Historical non-dementia mortality (MInterceptMAgeMtr1) 
Aggregate mortality is used to identify the search range 
for non- dementia mortality. A set of 1000 simulations are 
run initially with the dementia prevalence and incidence 
set to zero. The parameters for the best fitting simulations 
for both men and women were chosen using the calibra-
tion process described below, and were used as the basis 
for generating the non- dementia mortality rates.
Projected non-dementia mortality (Mtr2) 
The main assumption underlying the projections for the 
number of older people in Ireland is the rate of decline in 
mortality. While fertility and migration may have a signif-
icant impact on population projections for younger age 
cohorts, the population of older people is not as sensi-
tive to assumptions about fertility and migration over a 
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20- year horizon.41 The trend in mortality rates used here 
range from a continuation of the historical trend to trend 
declining to no yearly improvement over the projection 
period.
Dementia relative mortality (RMi) 
The mortality rates of people with dementia have been 
estimated in incidence studies to be in the region of 
twice those of non- dementia patients.42–45 A number of 
studies have shown variation in the relative mortality for 
different age groups. Relative mortality rates are elevated 
for younger dementia cases with little difference in the 
oldest age categories.28 42 46 47 In this study, the relative 
mortality for 65 year old age cohorts is selected from 
a range of 2 to 528, and allowed to decay with age such 
that the overall relative mortality rate for people with 
dementia is twice that of the non- dementia population. 
We assume that the relationship between dementia and 
non- dementia mortality RMi is allowed to vary by age but 
is constant over time.
Data
All historical population data, including data on the 
number and gender of people turning 65 each year are 
sourced from the Irish census for 1991, 1996, 2001, 2006, 
2011 and 2016. Population estimates for new cohorts of 
65 year olds are sourced from the Central Statistics Office 
projections, as are the number of deaths registered as 
being caused by dementia in 2018.41
Calibration
With the procedure described above we generate 5000 
simulations for men and women, both with and without 
dementia. Two approaches are used to attach greater 
weight to simulations that are more likely to reflect reality. 
First, all simulations where the number of deaths due to 
dementia are less than the number recorded in 2018 are 
excluded. While the recorded number of deaths attrib-
utable to dementia in Ireland is likely to be substantially 
below the true figure, due to low rates of diagnosis, using 
this data allows us to set a floor on dementia estimates.
Second, we weight the remaining simulations based 
on the difference between the simulated and observed 
census populations. A squared error term is generated by 
summing the squared error on the age distribution for 
each of the age categories from 65 to 98 in each of the five 










Where  Cit  and  C it are the number of people, in a 1 year 
age category, in the census and in the simulation, respec-










A weighted average number of dementia cases can then 
be generated using these weights. To show the possible 
range of trajectories, a fan plot is generated based on the 
simulations with the lowest error.
Patient and public involvement
People with dementia, through participation on the 
steering committee and the dementia advisory panel 
of the Centre for Economic and Social Research on 
Dementia, are involved in directing the programme of 
research of which this study is a component.
RESULTS
Model fit
The calibration approach used here allows 
us to identify the observed sets of parameters 
 (MIntercept, MCoef, Mtr1, Mtr2, RMi, I65, Igrowth, Itr)  that are most 
consistent with the observed Irish demographic data. 
Figure 1 show the population age distribution for 2016 
for the model with the lowest error from the full set of 
simulations. This shows that the best fitting simulations 
are closely aligned with the census for 2016.
Projected number of cases of dementia
Figure 2 shows a fan plot of the number of people with 
dementia based on 100 simulations with the lowest cali-
bration error for men and women (combined). The 
weighted average estimate of the number of cases of 
dementia for 2016 is 54 877 expanding to 98 946 by 2036, 
as shown in table 1. This latter projection for 2036 is 
substantially lower than previous projections (124 735) 
based on an extrapolation methodology.25 However, the 
plot shows the wide range of possible outcomes given 
the range in the available parameter estimates. The plot 
also shows that irrespective of whether the incidence rate 
is declining the number of cases of dementia is rapidly 
Figure 1 Population age distribution for 2016 for the 
simulation with the lowest error. Simulation estimates are 
shown in red and the observed census data are shown in 
yellow.
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increasing due to population ageing. A sensitivity analysis 
is provided in the online supplementary table 2.
DISCUSSION
The model developed in this paper demonstrates how 
census and cause of death data can be used to calibrate 
dementia projection models. We estimate a weighted 
average number of cases of dementia for Ireland of 54 
887 in 2016, increasing to 98 946 in 2036. The estimate for 
2036 is substantially lower than that obtained in previous 
studies using extrapolation methodology.
A key difference between this study and the previous 
modelling studies of dementia cases is the use of census 
and cause of death data to calibrate models.29 30 48 Previous 
studies have used parameter estimates from meta- analysis 
of the literature or from individual studies. In this paper 
we supplement these with a calibration approach. This 
approach allows additional sources of data such as census 
data and cause of death data to be used to customise the 
available estimates of dementia epidemiology in a country 
or region leading to more sensitive estimates. A second 
key difference between this study and previous modelling 
studies of dementia cases is the use of parameter ranges. 
Previous studies select a point estimate or show a limited 
number of scenarios. Using ranges rather than point esti-
mates allows for the substantial uncertainty in many of 
the parameter estimates to be represented.49
The projections generated in this study differ from those 
currently available based on extrapolation in a number of 
ways. First, they are consistent with Irish demographic and 
cause of death data. Second, they incorporate plausible 
parameter ranges—for example the possible decline in 
the incidence rate over time. Third, they show the range 
in the probable number of cases of dementia.
There are a number of limitations to the data and 
methods in this study. Cause of death records in Ireland 
are likely to significantly under- report dementia as the 
primary cause as (i) the practice of recording dementia 
as a primary cause of death has only commenced in 
2018 and (ii) due to low rates of diagnosis in Ireland.50 
Improvements in the recording of dementia as a cause 
of death in Ireland would assist in eliminating scenarios 
with low estimated dementia incidence, prevalence and 
mortality thus improving the calibration of the model 
and narrowing the credible range of estimates. While the 
calibration procedure outlined in this paper can improve 
on an un- calibrated projection, care is still required in 
choosing the mean and distribution of the chosen param-
eters. The weighted average number of cases reported in 
table 1 will be influenced by the range and distribution of 
parameter values. A time trend in the relative mortality of 
people with dementia was not included in this study due 
to a lack of literature in this area to guide parameter selec-
tion.51 Dementia relative mortality could be increasing, 
for example, if people with dementia are not getting the 
benefits of technological improvements, or declining, if 
people with dementia are now receiving treatments that 
they would not have in the past due to changes in how 
people with dementia are perceived.
In the context of increasing prevalence of dementia 
globally and the targets set out in the WHO Global Action 
Plan on Dementia,52 countries are developing plans which 
will require investment in new service development and 
a greater quantum of existing services. The best possible 
incidence and prevalence estimates are required to aid 
this future planning. There are significant policy and care 
implications to using prevalence estimates that are too 
low or too high. For example, using an estimate for the 
number of people with dementia that was too low might 
suggest to service planners that there would not be suffi-
cient demand for a service at a local level, for example, 
day care.53 Alternatively, using an estimate that was too 
high would overstate the cost of providing a new service, 
for example, providing post- diagnostic support to all 
newly diagnosed people with dementia.54
The methodology used in this study would be most 
effective in countries or regions with relatively frequent 
census, high rates of dementia diagnosis and high quality 
Figure 2 Fan plot of the estimated number of people with 
dementia. The weighted average of all simulations is shown 
in Blue. Colours depict percentiles of the distribution of the 
number of cases of dementia from the 100 simulations with 
the lowest calibration error.
Table 1 The weighted mean number of people with dementia from all simulations, aged 65 to 98, for 2016 and projected 
census years
2016 2021 2026 2031 2036
Weighted mean 54 877 64 888 75 287 87 023 98 946
Weighted SD (9804) (11 769) (13 763) (16 020) (18 320)
Annual growth rate 3.0%
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cause of death data. The next census in Ireland is due 
in 2021, this can be added to the calibration exercise to 
improve these estimates. The methodology used in this 
study could also be applied to other diseases, such as 
diabetes, or for other purposes such as budget impact 
analysis.
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